Get the Stockscreener App
14.68
0.88%
-0.13
After Hours:
14.42
-0.26
-1.77%
Si Bone Inc stock is traded at $14.68, with a volume of 306.45K.
It is down -0.88% in the last 24 hours and up +5.84% over the past month.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
See More
Previous Close:
$14.81
Open:
$14.99
24h Volume:
306.45K
Relative Volume:
0.43
Market Cap:
$651.05M
Revenue:
$200.93M
Net Income/Loss:
$-18.91M
P/E Ratio:
-33.22
EPS:
-0.4419
Net Cash Flow:
$-9.09M
1W Performance:
+3.67%
1M Performance:
+5.84%
6M Performance:
-24.72%
1Y Performance:
-20.30%
1-Day Range:
$14.46
$15.10
1-Week Range:
$14.20
$15.10
52-Week Range:
$11.48
$21.89
Si Bone Inc Stock (SIBN) Company Profile
Name
Si Bone Inc
Sector
Industry
Phone
(408) 207-0700
Address
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
14.68 | 656.81M | 200.93M | -18.91M | -9.09M | -0.4419 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| Mar-28-24 | Initiated | Piper Sandler | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Apr-07-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-08-21 | Initiated | Citigroup | Buy |
| Mar-09-21 | Reiterated | Needham | Buy |
| Dec-16-20 | Reiterated | Needham | Buy |
| Aug-04-20 | Reiterated | Needham | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| May-05-20 | Reiterated | Needham | Buy |
| Feb-19-20 | Initiated | Needham | Buy |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Dec-18-19 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-12-18 | Initiated | BofA/Merrill | Buy |
| Nov-12-18 | Initiated | Canaccord Genuity | Buy |
| Nov-12-18 | Initiated | JMP Securities | Mkt Outperform |
| Nov-12-18 | Initiated | Morgan Stanley | Overweight |
View All
Si Bone Inc Stock (SIBN) Latest News
SI-BONE's strong revenue growth hasn't boosted its share price, raising questions about market sentiment or underlying issues. Caution is advised for investors, with analysts taking a neutral to slightly bearish stance until profitability or improvement is shown. - Moomoo
Si-Bone CFO Anshul Maheshwari sells $68,523 in shares - Investing.com India
Si-Bone CFO Anshul Maheshwari sells $68,523 in shares By Investing.com - Investing.com Nigeria
Si-Bone CEO Laura Francis sells $220,000 in company stock - Investing.com
Si-Bone CEO Laura Francis sells $220,000 in company stock By Investing.com - Investing.com Australia
SI-BONE (SIBN) CEO Laura Francis sells 14,957 shares to cover RSU tax bill - Stock Titan
SI-BONE (SIBN) legal chief sells 3,726 shares in tax sell-to-cover - Stock Titan
Tax-related SI-BONE (SIBN) CFO sale of 4,666 shares disclosed - Stock Titan
Earnings call transcript: Si-Bone Q1 2026 beats EPS forecast, stock rises - Investing.com Nigeria
(SIBN) Volatility Zones as Tactical Triggers - Stock Traders Daily
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27% - Yahoo Finance
SI-BONE stock (US8255921098): Q1 beat and raised FY26 guidance drive gains - AD HOC NEWS
Analysts Have Been Trimming Their SI-BONE, Inc. (NASDAQ:SIBN) Price Target After Its Latest Report - simplywall.st
SiBone $SIBN Shares Bought by HighMark Wealth Management LLC - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: SI-Bone (SIBN), Perspective Therapeutics (CATX) - The Globe and Mail
SI-BONE (SIBN) Reports Strong Q1 Earnings and Raises Full-Year G - GuruFocus
Why Si-Bone Stock Soared by Almost 20% on Tuesday - The Motley Fool
Why Si-Bone Stock Soared by Almost 20% on Tuesday - The Motley Fool
SI-BONE 1Q Loss/Shr 10c >SIBN - Moomoo
CCORF Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27 - 富途牛牛
TD Cowen Maintains Si-Bone(SIBN.US) With Buy Rating, Cuts Target Price to $18 - Moomoo
SIBN Maintained by TD Cowen -- Price Target Lowered to $18 - GuruFocus
SIBN Reiterated by Truist Securities -- Price Target Lowered to $18.00 - GuruFocus
Truist cuts SI-BONE stock price target on conservative guidance By Investing.com - Investing.com Australia
Truist cuts SI-BONE stock price target on conservative guidance - Investing.com UK
SI-BONE targets $230M-$233M 2026 revenue while CMS proposes new DRGs that could add up to $50,000 per Granite procedure - MSN
SI-BONE, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SIBN) 2026-05-12 - Seeking Alpha
SI-BONE, Inc. (NASDAQ:SIBN) Q1 2026 Earnings Call Transcript - Insider Monkey
SI-BONE net loss hits USD 4.3M in Q1 2026 - Medical Buyer
Needham Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $27 - Moomoo
Truist Lowers Price Target on SI-BONE to $18 From $20, Keeps Buy Rating Rating - Moomoo
SI-BONE Inc (SIBN) Q1 2026 Earnings Call Highlights: Strong Reve - GuruFocus
SI-BONE Surges on Strong Q1, Raises Guidance Amid Innovation Push - BriefGlance
SI-BONE Q1 2026 slides: profitability surges, physician base expands By Investing.com - Investing.com Australia
SiBone Q1 Earnings Call Highlights - inkl
Morgan Stanley Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $18 - Moomoo
SiBone Q1 2026 Earnings Call Transcript - MarketBeat
Is SI-BONE (SIBN) Still 45.2% Undervalued After Q1 2026 Beat? EP - GuruFocus
SIBN Reports Positive Outlook with Strong Gross Margin - GuruFocus
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
SIBN Reports Strong Q1 Performance with Revenue Growth - GuruFocus
SIBN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SI-Bone (SIBN) Q1 2026 Earnings Transcript - The Globe and Mail
Si Bone Inc Stock (SIBN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):